STRM Streamline Health Solutions Inc
Price (delayed)
$2.74
Market cap
$11.71M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.41
Enterprise value
$23.22M
Streamline Health Solutions, Inc. is a leader in pre-bill revenue integrity solutions for healthcare providers. Its eValuator™ Revenue Integrity Program includes integrated solutions, technology-enabled services and analytics that drive compliant
Highlights
The company's EPS has surged by 53% YoY and by 51% QoQ
STRM's net income has soared by 52% year-on-year and by 50% since the previous quarter
The equity has decreased by 30% YoY and by 12% from the previous quarter
The company's quick ratio fell by 27% QoQ and by 25% YoY
Key stats
What are the main financial stats of STRM
Market
Valuations
Earnings
Shares outstanding
4.27M
Market cap
$11.71M
Enterprise value
$23.22M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.83
Price to sales (P/S)
0.6
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.25
Revenue
$18.59M
Gross profit
$9.1M
Operating income
-$7.55M
Net income
-$9.39M
EBIT
-$7.63M
EBITDA
-$2.97M
Free cash flow
-$3.37M
Per share
Balance sheet
Liquidity
EPS
-$2.41
EPS diluted
-$2.41
Free cash flow per share
-$0.83
Book value per share
$3.3
Revenue per share
$4.58
TBVPS
$1.65
Total assets
$35.97M
Total liabilities
$22.05M
Debt
$12.26M
Equity
$13.91M
Working capital
-$6.46M
Debt to equity
0.88
Current ratio
0.46
Quick ratio
0.41
Net debt/EBITDA
-3.88
Margins
Efficiency
Dividend
EBITDA margin
-16%
Gross margin
49%
Net margin
-50.5%
Operating margin
-40.6%
Return on assets
-23.7%
Return on equity
-57%
Return on invested capital
-133.2%
Return on capital employed
-31.6%
Return on sales
-41%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
STRM stock price
How has the Streamline Health Solutions stock price performed over time
Intraday
0.76%
1 week
-13.56%
1 month
-25.75%
1 year
-62.72%
YTD
-27.13%
QTD
-2.15%
Financial performance
How have Streamline Health Solutions's revenue and profit performed over time
Revenue
$18.59M
Gross profit
$9.1M
Operating income
-$7.55M
Net income
-$9.39M
Gross margin
49%
Net margin
-50.5%
STRM's operating income has surged by 63% year-on-year and by 59% since the previous quarter
The operating margin has soared by 55% from the previous quarter and by 52% YoY
STRM's net income has soared by 52% year-on-year and by 50% since the previous quarter
Streamline Health Solutions's net margin has increased by 46% QoQ and by 38% YoY
Growth
What is Streamline Health Solutions's growth rate over time
Valuation
What is Streamline Health Solutions stock price valuation
P/E
N/A
P/B
0.83
P/S
0.6
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.25
The company's EPS has surged by 53% YoY and by 51% QoQ
The price to book (P/B) is 62% lower than the 5-year quarterly average of 2.2 and 36% lower than the last 4 quarters average of 1.3
The equity has decreased by 30% YoY and by 12% from the previous quarter
The stock's price to sales (P/S) is 82% less than its 5-year quarterly average of 3.3 and 41% less than its last 4 quarters average of 1.0
The revenue has declined by 22% year-on-year and by 8% since the previous quarter
Efficiency
How efficient is Streamline Health Solutions business performance
Streamline Health Solutions's return on invested capital has surged by 77% YoY and by 61% QoQ
The company's return on sales has surged by 52% QoQ and by 47% YoY
The company's return on assets rose by 48% QoQ and by 35% YoY
Streamline Health Solutions's ROE has increased by 46% from the previous quarter and by 13% YoY
Dividends
What is STRM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for STRM.
Financial health
How did Streamline Health Solutions financials performed over time
Streamline Health Solutions's total assets is 63% more than its total liabilities
The company's quick ratio fell by 27% QoQ and by 25% YoY
STRM's current ratio is down by 25% since the previous quarter and by 25% year-on-year
Streamline Health Solutions's debt is 12% lower than its equity
STRM's debt to equity has soared by 76% YoY and by 13% from the previous quarter
The equity has decreased by 30% YoY and by 12% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.